6 reports

In total ## patients were enrolled (of whom ## ongoing)## with tumour genomic profiles## (##%) with at least one actionable mutation.

  • Genetic
  • Genomics
  • France
  • Western Europe
  • Demand

IN TOTAL ## PATIENTS WERE ENROLLED (OF WHOM ## ONGOING)## WITH TUMOUR GENOMIC PROFILES## (##%) WITH AT LEAST ONE ACTIONABLE MUTATION.

  • Genomics
  • Medical Device
  • Western Europe
  • Forecast
  • bioMerieux S.A.

AT THE MOMENT ONE CANNOT IN GOOD FAITH ADVISE A WOMAN WITH A HIGH CLINICAL RISK AND LOW GENOMIC RISK TO OMIT CHEMOTHERAPY.

  • Genomics
  • Germany
  • Western Europe
  • Forecast
  • QIAGEN N.V.

In total ## patients were enrolled (of whom ## ongoing)## with tumour genomic profiles## (##%) with at least one actionable mutation.

  • Genomics
  • Western Europe
  • Company Financials
  • Demand
  • QIAGEN N.V.

Other genetic tests include pharmaco-genomics which include test related to cytochrome P## (CYP ##).

  • Genomics
  • Medical Device
  • France
  • Western Europe
  • bioMerieux S.A.

It binds to the integrin LFA-## (lymphocyte function-associated antigen-##), a cell surface protein found on leukocytes, and blocks the interaction of LFA-## with its cognate ligand ICAM-## (intercellular adhesion molecule-##).

  • Genomics
  • In Vitro Diagnostics
  • Germany
  • Western Europe
  • QIAGEN N.V.